Apple (AAPL): Update From Japan - Mizuho
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Mizuho Securities analyst, Abhey Lamba, reiterated his Buy rating on shares of Apple (NASDAQ: AAPL) after getting additional detail from the team in Japan. The Mizuho Japan team has largely maintained its iPhone procurement estimates for C2H16, although, production estimates are more fourth quarter weighted due to iPhone 7 ramp delays. The analyst maintains existing sell-in estimates going into C2H and notes that consensus iPhone estimate cuts have abated in recent months. He believes the reversal of estimate cuts is a "de-risking" and sees a compelling risk/reward on attractive valuation and potential upside due to the product cycle.
No change to the price target of $120.
Shares of Apple closed at $106.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple (AAPL) PT Raised to $148 at Macquarie; Services Segment Remains 'Underappreciated and Misunderstood'
- Drexel Hamilton Reiterates Buy on IBM (IBM) Following 4Q Report
- Active options: AAPL IBM ARNC FB BAC SWKS AMZN GE NFLX SGYP
Create E-mail Alert Related CategoriesAnalyst Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!